Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Brian Roark on Medicare Billing Fraud for Healthcare Risk Management

Media Mentions

January 25, 2010

Brian Roark, attorney at Bass, Berry & Sims, is extensively quoted regarding Medicare billing fraud for Healthcare Risk Management. The article, titled "Avoid Being Drawn Into Billing Fraud," discussing seven recent cases of fraudulent Medicare billing totaling $26 million in unneeded or undelivered medical equipment, was published on January 1, 2010.

From the article:

Such brazen fraud likely would not go unnoticed by a risk manager if it originated within the organization, but it still is possible to get involved in these schemes unless you take the right precautions, says Brian D. Roark, JD, an attorney with the law firm of Bass, Berry and Sims in Nashville, TN.

"On the criminal side, the federal government is devoting significant resources to prosecuting street-level fraud cases where Medicare or Medicaid is billed for services not rendered, such as individuals setting up fake medical supply companies," he says. "Additionally, the government is employing increasingly sophisticated investigative techniques to spot fraud, such as using data mining to find aberrations in claims-filing patterns and using prepayment claims editing to compare new claims to previous claims and detect fraud in almost real time. Some of the primary areas of focus by the government are on durable medical equipment [DME], prosthetics, orthotics and supplies, home health agencies, and infusion therapy."

Roark also points out that the Fraud Enforcement and Recovery Act of 2009 (FERA) made significant amendments to the False Claims Act (FCA), which is the primary civil enforcement tool for health care fraud. The result of the FERA amendments was to expand liability under the FCA, take away certain defenses previously available to defendants, make it easier for the government to share information with qui tam whistle-blower plaintiffs, and expand whistle-blower protections.

"The FERA amendments likely will increase the number of FCA lawsuits brought against health care providers," Roark says.

Roark says a key way to avoid involvement in such fraud is to make compliance the responsibility of the entire organization and provide mechanisms for employees to raise any compliance concerns.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.